RESTEM and JAR of Hope Foundation Announce Strategic Partnership and Clinical Trial Launch of Next-Generation Cell Therapy for Patients with Duchenne Muscular Dystrophy

Corona, CA and Asbury Park, NJ (PRWEB) September 06, 2022 -- RESTEM and JAR of Hope Foundation Announce Strategic Partnership and Clinical Trial Launch of

Related Keywords

California ,United States ,New Jersey ,Rafael Gonzalez ,Jim Raffone ,James Raffone ,David Pyrce ,Anthony Raffone ,Drug Administration ,Duchenne Muscular ,Duchenne Muscular Dystrophy ,Senior Vice President ,Investigational New Drug Application ,Umbilical Cord Lining ,Press Release ,